MedTrace Logo

Home Monitoring for Atrial Fibrillation Using a Microlife Blood Pressure Monitor

NCT00861354 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2010-01-08

No results posted yet for this study

Summary

This study assess the accuracy of a blood pressure monitor designed to detect atrial fibrillation. Subjects use the blood pressure monitor on a daily basis for 30 days and compare the readings to an ECG done at the same time.

Conditions

Interventions

DEVICE

Microlife blood pressure monitor with AF detection (Microlife AFIB MLU3MQ1)

Monitoring heart rhythm daily for 30 days using the blood pressure monitor and the ECG recorder.

Sponsors & Collaborators

  • Microlife

    lead INDUSTRY

Principal Investigators

  • Joseph Wiesel, MD

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2009-09-30
Completion
2009-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00861354 on ClinicalTrials.gov